Literature DB >> 8462824

Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes.

W A Kmiot1, S R Hesslewood, N Smith, H Thompson, L K Harding, M R Keighley.   

Abstract

BACKGROUND: The aim of this study was to elucidate the inflammatory infiltrate in pouchitis and define the changes following metronidazole therapy.
METHODS: Twenty-seven patients underwent functional grading, sigmoidoscopic and histological scoring, 111In-labeled granulocyte scanning, and 4-day fecal collections for 111In-labeled granulocyte excretion. Six of the patients with pouchitis underwent repeat studies after 1-month treatment with metronidazole, 400 mg three times daily.
RESULTS: The grade of macroscopic inflammation in the pouch mucosa (sigmoidoscopic score) correlated well with the acute histological score (P < 0.0001), chronic histological score (P < 0.001), 4-hour 111In scan (P < 0.001), 24-hour 111In scan (P < 0.001), and with 4-day fecal 111In excretion (P < 0.001). After metronidazole therapy there was decreased inflammatory grade sigmoidoscopically and histologically on the 4- and 24-hour scans and decreased 4-day fecal 111In granulocyte excretion.
CONCLUSIONS: This study confirms that the inflammatory infiltrate in pouchitis is acute or chronic, is characterized by neutrophils, is usually localized to pouch mucosa, and is always decreased after metronidazole therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462824     DOI: 10.1016/0016-5085(93)90264-d

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Pouch permeability: breaching barriers to understanding pouchitis?

Authors:  I Bjarnason; I Menzies; A Macpherson
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

2.  Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis.

Authors:  U Keränen; H Järvinen; T Kiviluoto; E Kivilaakso; S Soinila
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

3.  Substance P--an underlying factor for pouchitis? Prospective study of substance P- and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells.

Authors:  U Keränen; H Järvinen; P Kärkkäinen; T Kiviluoto; E Kivilaakso; S Soinila
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

Review 4.  The labeled-leukocyte scan in the study of abdominal abscesses.

Authors:  Mauro Liberatore; Enrico Calandri; Gabriele Ciccariello; Marzia Fioravanti; Valentina Megna; Lucia Rampin; Maria Cristina Marzola; Imene Zerizer; Adil Al-Nahhas; Domenico Rubello
Journal:  Mol Imaging Biol       Date:  2010-12       Impact factor: 3.488

Review 5.  Diagnosis and treatment of patients with pouchitis.

Authors:  Bo Shen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue.

Authors:  Ulf Helwig; Paolo Gionchetti; Fernando Rizzello; Karen Lammers; Tanja Kühbacher; Stefan Schreiber; Marco Baggiolini; Mariagrazia Uguccioni; Massimo Campieri
Journal:  Int J Colorectal Dis       Date:  2003-06-25       Impact factor: 2.571

7.  Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Authors:  Nghia Nguyen; Bing Zhang; Stefan D Holubar; Darrell S Pardi; Siddharth Singh
Journal:  Cochrane Database Syst Rev       Date:  2019-05-28

8.  Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Authors:  Nghia Nguyen; Bing Zhang; Stefan D Holubar; Darrell S Pardi; Siddharth Singh
Journal:  Cochrane Database Syst Rev       Date:  2019-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.